Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Agilent Completes Acquisition of Biocare Medical | Contract Pharma

What are you searching for?

Sign in
Breaking News

Agilent Completes Acquisition of Biocare Medical

Expands Agilent’s pathology portfolio and ability to serve customers across clinical and research settings.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma
Agilent

Agilent Technologies Inc. has successfully completed its previously announced acquisition of Biocare Medical, a global clinical pathology provider, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.

Agilent acquired Biocare in an all-cash transaction valued at $950 million to enhance its pathology portfolio. Biocare’s pathology products focus on immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) diagnostic techniques for patients with cancer. The company has developed more than 300 specialized antibodies.

“We are pleased to complete our acquisition of Biocare, which represents a natural and strategic expansion of Agilent’s pathology portfolio and strengthens our ability to serve customers across clinical and research settings,” said Agilent President and CEO Padraig McDonnell. “At Agilent, we remain focused on investing in areas where we see clear opportunities to enhance our capabilities, accelerate customer-centric innovation and create long-term value for our shareholders. With Biocare’s talented team and complementary portfolio now part of Agilent, we are well positioned to build on our momentum and further support the evolving needs of our customers and partners.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics